Skip to main content
. 2021 Jan 9;33:102350. doi: 10.1016/j.nano.2020.102350

Table 2.

Applications of CRISPR-Cas9 system in cardiovascular diseases.

Sr. no. Name of cardiovascular diseases Target cell/tissue/organ Target gene Application Name model organism Vector used Reference
1. Cardiomyopathy Cardiomyocytes Myh6 Demonstrated the role of Myh6 in heart function Mice Adeno-associated virus 102
2. Atherosclerosis Embryo Apolipoprotein E (ApoE) and low density lipoprotein receptor (LDLR) To study human cardiovascular disease by accessing the level of biochemical constituents Pigs Genome editing 107
Fibroblast and myoblast Mef2d and Klf15 loci Controlling transcription in cardiomyocytes of the postnatal heart Mice Genome editing 108
3. Cardiac dysfunction Lineage-negative bone marrow cells TET2 and Dnmt3a Role of targeted genes in cardiac dysfunction and renal fibrosis Mice Lentivirus 109
4. Duchenne muscular dystrophy C2C12 mouse myoblasts Dmd exon 44 Restoration of dystrophin protein expression Mice Adeno-associated virus 110
5. Atherosclerosis Hepatocytes Low-density lipoprotein receptor (LDLR) Effective therapeutic approach for the treatment of familial hypercholesterolemia Mice Adeno-associated virus 111